Search results

Found 10682 matches for

UK Research and Innovation, Cancer Research UK and industry are investing more than £11 million in an Oxford-led artificial intelligence (AI) research programme to improve the diagnosis of lung cancer and other thoracic diseases.

Tumour Immunology

Tumour Microenvironment

Understanding how to manipulate a tumour's microenvironment and how can use this understanding for therapeutic gain.

DNA Damage & Repair

Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research

Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.

Prof. Ester Hammond and Dr Monica Olcina travel to Warsaw for the first meeting of the EU Horizon funded consortium – HIT-GLIO

Researchers develop easy-to-deploy federated learning system that safeguards patient data

The technique, which builds on recent advances in decentralised machine learning, uses inexpensive pre-programmed micro-computers, making it easy to deploy in hospitals and cheap to scale up.

Oxford gets £122m funding for healthcare research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. The funding was awarded to the city’s two National Institute for Health and Care Research (NIHR) Biomedical Research Centres (BRC).

Cancer Research UK to invest £11 million into cancer science in Oxford

Eileen Parkes secures Clinical Research Career Development Fellowship

Eileen is awarded funding for her research into the tumour microenvironment

Cookies on this website

Search results

Found 10682 matches for

Similar stories